Loading...
NPI 1518152420 · Stateline, NV · Dermatology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Martin Salm is a dermatology physician provider located in Stateline, Nevada. This profile covers 81 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Martin Salm |
| Address | 276 Kingsbury Grade, Suite 101 |
| City | Stateline |
| State | NV |
| ZIP | 89449 |
| Taxonomy | Dermatology Physician |
| NPI Enumerated | September 13, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.2M |
| Medicaid | $12.6K |
Practice profile and service mix indicate a dermatology practice strongly focused on lesion destruction and office-based procedural care: high-revenue Medicare codes include 17311 (Mohs surgery, $123.2K), 17110 (destruction of benign lesions, $100.4K), and 99213 (office E/M, $78.8K), and the broader CPT mix also lists repair and graft codes (14040, 14060, 15260) plus pathology (88305). These entries suggest a workflow combining high-volume lesion destruction and cryosurgery, regular pathology specimen processing, and occasional reconstructive procedures post-excision rather than a predominantly cosmetic or exclusively medical dermatology practice.
Revenue concentration on Medicare is meaningful but not extreme: the precomputed top-3 Medicare codes account for 32.2% of the provider's total Medicare revenue, and those top three codes are 17311, 17110, and 99213. This indicates a concentrated set of revenue drivers on Medicare (procedural lesion treatment and routine E/M visits) while the remainder of Medicare revenue is spread across many other procedure and pathology codes.
Medicaid revenue is highly concentrated and effectively marginal to the operation: total Medicaid revenue is $12.6K compared with $1.2M in Medicare, and the precomputed top-3 Medicaid codes (99212, 88305, 99213) account for 92.2% of the provider's Medicaid revenue. In practical terms this provider is Medicare-dominant in scale, with Medicaid representing a very small, concentrated portion of billing activity.
Competitive standing on specific high-volume Medicare codes shows several national extremes: 17110 ranks #40 of 19650 (100th percentile) and is labeled an extreme outlier, and 17003 ranks #29 of 19643 (100th percentile) and is also an extreme outlier, signaling unusually high national volume for lesion-destruction add-on units. Similarly, 99213 ranks #3319 of 457151 (99th percentile) and is noted as an extreme outlier, indicating unusually large office visit volumes relative to national peers and reinforcing a high throughput ambulatory practice.
Other Medicare codes reflect typical or modest national participation: 17311 (Mohs) ranks #1142 of 2969 (61th percentile) and 88305 (pathology) ranks #1247 of 14580 (91th percentile), both described as typical or unremarkable volumes. This pattern suggests the provider performs Mohs and pathology at a scale that is within the normal range for specialists, while excision and lesion-destruction workload (other codes) drive unusually high volumes.
Medicaid competitive standing within the state is muted: 99212 ranks #232 of 536 (57th percentile) and is described as typical, while 88305 and 99213 rank in the lower in-state percentiles (20th and 24th respectively), indicating the provider is not a leading Medicaid performer for pathology or higher-level E/M services in-state. The Medicaid profile therefore reads as a low-volume, routine ambulatory presence rather than a major Medicaid-facing operation.
Operational implications for payers: the combination of extreme outlier volumes for lesion-destruction codes (17110, 17003) and high counts for low-level E/M (99212/99213) implies a high-volume, procedure-driven ambulatory clinic model where many patients are seen for lesion treatments during routine visits. For network planning or utilization review this suggests focusing oversight and resource alignment on high-frequency procedural workflows and pathology interfaces.
Tenure and stability: the provider's NPI was enumerated on 2007-09-13 (~19 years ago), indicating a long-standing practice presence in Stateline, NV. That longevity, combined with concentrated Medicare revenue ($1.2M) and high-volume procedural coding, supports the view of an established, procedure-focused dermatology practice with a modest Medicaid footprint ($12.6K).
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
81 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 17311 | Mohs surgery is a multi–staged procedure that is performed to excise a malignant lesion layer by layer, along with histo–pathological assessment. The assessment is performed to ensure that the… | 310 | $400 | $123.2K |
| 17110 | The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of one to 14 lesions other than skin tags or… | 1,500 | $70 | $100.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,290 | $60 | $78.8K |
| 17004 | The provider destroys 15 or more premalignant lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. | 640 | $120 | $78.4K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 2,680 | $30 | $77.7K |
| 17312 | Mohs surgery is a multi–staged method of excising a malignant lesion layer by layer, along with histo–pathological assessment, to ensure negative malignancy of the margins. | 220 | $330 | $72.8K |
| 17003 | In this add–on procedure, the provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code is appropriate for the second through… | 11,410 | $10 | $57K |
| 17000 | The provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of the first or only lesion. | 1,600 | $30 | $44.7K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 1,230 | $40 | $44.3K |
| 14040 | The provider repairs lesions in the patient’s forehead, cheeks, chin, mouth, neck, axillae or armpits, genitalia, hands, and/or feet by using healthy tissues from an adjacent site. This code… | 40 | $610 | $26.9K |
Showing 1–10 of 81
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 81 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
81 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 17311 | 13 | 30 | 220 | $450 | $109K |
| 88305 | 9 | 80 | 500 | $40 | $59.3K |
| 17312 | 10 | 30 | 150 | $320 | $56.1K |
| J7345 | 8 | 10 | 14,100 | $1 | $26.8K |
| 15260 | 11 | 10 | 30 | $740 | $22.8K |
| 14060 | 4 | 20 | 40 | $570 | $20.6K |
| 99214 | 1,373 | 3,610 | 110 | $80 | $19K |
| 14040 | 2 | 10 | 30 | $590 | $18.8K |
| 14061 | 6 | 10 | 20 | $780 | $17.9K |
| 13132 | 14 | 40 | 50 | $210 | $17.6K |
Showing 1–10 of 81
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 170 | $40 | $6.2K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 50 | $60 | $2.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 80 | $30 | $2.5K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 10 | $80 | $990 |
How this provider's Medicaid billing volume and revenue compare to other Nevada providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Nevada median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,869 | 2,480 | 330 | $50 | $107.6K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 75 | 90 | 200 | $20 | $71.6K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 776 | 860 | 100 | $70 | $42.9K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 232 | 540 | 130 | $30 | $28K |
Other providers in the same ZIP code as Martin Salm, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Susan Meller | NV | Internal Medicine Physician | $2.7M | $0 |
| Maverick Medical, Inc. | NV | Durable Medical Equipment & Medical Supplies | $0 | $1.4M |
| Robert Rupp | NV | Sports Medicine (Orthopaedic Surgery) Physician | $102K | $0 |
| Jay Chung | NV | Rheumatology Physician | $54.3K | $0 |
| Tania Dickson-humphries | NV | Physician Assistant | $27.6K | $0 |
| Eric Ewald | NV | Family Medicine Physician | $24.3K | $0 |
| Stuart Michelson | NV | Emergency Medicine Physician | $19.1K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.